Search the Site
Follow TheCancerLetter on Twitter
join our mailing list

Enter your name and email address to receive an update when we post new content.

IP Login

The Clinical Cancer Letter, December 2011

publication date: Dec 23, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
  • Velcade Increases Overall Survival by 13.3 Months in Multiple Myeloma
  • Perifosine Increases PFS in Lymphoma Phase II Study
  • Researchers Identify Nine Cancer Genes--Five Linked to CLL for the First Time


To access this members-only content, please log in.

If you're not a subscriber why not join today?

If you believe you should be able to view this area but cannot log in, then please contact us and we will try to rectify this issue as soon as possible.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.